|
|
||||||||
CLINICAL STUDY |
Endocrinology Unit, Department of Medical and Surgical Sciences, and 1 Laboratory of Clinical Pathology, Institute of General Pathology, University of Milano, Policlinico San Donato, Via Morandi 30, I-20097 San Donato, Milano, Italy and 2 Echocardiographic Unit, Policlinico San Donato, San Donato Milanese, Milano, Italy
(Correspondence should be addressed to B Ambrosi; Email: bruno.ambrosi{at}unimi.it)
Objective: Obesity can be considered a state of chronic, low-grade inflammation. Particularly, visceral adipose tissue (VAT) seems to be an active compartment in pro-inflammatory molecule secretion. Adipocytes and VAT are able to produce large amounts of monocyte chemoattractant protein 1 (MCP-1), a chemokine directly involved in ventricular remodeling.
Design: In this study, the possible existence of a correlation between MCP-1, abdominal fat accumulation and echocardiographic abnormalities in uncomplicated obesity was investigated.
Methods: Echocardiographic parameters, MCP-1 and C-reactive protein (CRP) levels were assessed in 27 normotensive obese women of fertile age (body mass index 43.5 ± 4.8 kg/m2, mean ± S.D.) and 15 normal weight women. Visceral fat (VAT) in the obese group was assessed by computed tomography.
Results: Obese patients had higher MCP-1 (P < 0.0001) and CRP (P < 0.0001) levels than controls. MCP-1 levels were correlated with VAT area (r = 0.57, P < 0.0001), CRP (P < 0.0001), left ventricular mass (LVM) (P < 0.02), LVM indexed for height (P < 0.03), end-diastolic posterior wall (P < 0.005), relative wall thickness (P < 0.01), early diastolic filling wave velocity (P < 0.01), isovolumetric relaxation time (P < 0.001) and deceleration time (P < 0,01). Obese patients with greater amounts of VAT (> 130 cm2) presented higher MCP-1 (P < 0.0001) and CRP levels (P < 0.04) than those with a lower degree of abdominal adiposity.
Conclusions: MCP-1 levels and visceral adipose tissue seem to be associated with some morphological and functional echocardiographic abnormalities and support a role for visceral fat in predisposing the subject to cardiac dysfunction, possibly through a low-grade state of inflammation.
This article has been cited by other articles:
![]() |
Z. Zhang, G. Cherryholmes, A. Mao, C. Marek, J. Longmate, M. Kalos, R. P. ST. Amand, and J. E. Shively High Plasma Levels of MCP-1 and Eotaxin Provide Evidence for an Immunological Basis of Fibromyalgia Experimental Biology and Medicine, September 1, 2008; 233(9): 1171 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Malavazos, F. Ermetici, L. Morricone, A. Delnevo, C. Coman, B. Ambrosi, and M. M. Corsi Association of Increased Plasma Cardiotrophin-1 With Left Ventricular Mass Indexes in Normotensive Morbid Obesity Hypertension, February 1, 2008; 51(2): e8 - e8. [Full Text] [PDF] |
||||
![]() |
I. S. Vlachos, A. Hatziioannou, A. Perelas, and D. N. Perrea Sonographic Assessment of Regional Adiposity Am. J. Roentgenol., December 1, 2007; 189(6): 1545 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cereda, V. Sansone, G. Meola, and A. E. Malavazos Increased visceral adipose tissue rather than BMI as a risk factor for dementia Age Ageing, September 1, 2007; 36(5): 488 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cereda and A. E. Malavazos A Possible Role of Visceral Fat-Related Inflammation in Linking Obstructive Sleep Apnea to Left Ventricular Hypertrophy Hypertension, April 1, 2007; 49(4): e23 - e23. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |